News

Merck price target lowered to $82 from $89 at BMO Capital
BMO Capital analyst Evan Seigerman lowered the firm’s price target on Merck (MRK) to $82 from $89 and keeps a Market Perform rating on the ...
Opinion
Citi Remains a Buy on Merck & Company (MRK)
In a report released today, Geoff Meacham from Citi maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target ...